MIRA INFORM REPORT

 

 

Report Date :

10.02.2014

 

IDENTIFICATION DETAILS

 

Name :

GENPHARMA (INTERNATIONAL) PRIVATE LIMITED

 

 

Registered Office :

C-7-8(2), MIDC, Bhosari, Pune-411026, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

21.11.2003

 

 

Com. Reg. No.:

11-130003

 

 

Capital Investment / Paid-up Capital :

Rs.7.956 Millions

 

 

CIN No.:

[Company Identification No.]

U24230PN2003PTC130003

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Medicines.

 

 

No. of Employees :

130 [Approximately] 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 487700

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having moderate track record. Management of the company has failed to file its financials from 2011 with government department.

 

Mr. Abhijeet Mane, Accounts Manager provided general information and also provided turnover of FY 2011-12 is Rs.43.000 Millions and FY 2012-13 is Rs.12.000 Millions, which is not verified.

 

As per previous available, company has incurred loss from its operation in the year 2010.

 

However, trade relation reported to be fair. Business is active. Payment terms are reported to be slow.

 

The company can be considered for business dealing with great caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The services sector, the largest contributor to India’s GDP, contracted for the sixth consecutive month in December, as orders dipped. However, hiring has risen.  Direct tax collections rose 12.3 % during the April – December period of the current financial year.  The government has decided to retain 100 per cent foreign direct investment in both greenfield (new) and brown field (existing) pharmaceutical companies, despite concerns over genetic drugs going out of production, if multi-national companies take over domestic ones. In M&A deals, a non compete clause would not be allowed, except in special circumstances. The Department of Industrial Policy and Promotion plans to release the next edition of its consolidated foreign direct investment policy document on March 31, incorporating changes made in the past year. DIPP compiles all policies related to India’s FDI regime into a single document to make it easy for investors to understand. 185 million estimated number of mobile internet users in India by June 2014, according to a report by the Internet & Mobile Association of India and IMRB International.  India had 110 million mobile internet users with 25 million in rural areas. $3.77 tn estimated global IT spending in 2014, according to research firm Gartner Inc. The growth forecast for this year is cut to 3.1 %from the earlier estimate of 3.5 %. The spending growth forecast for telecom services – a segment that accounts for more than 40 % at total IT spending – from 1.9 per cent to 1.2 per cent is the main reason for this overall IT cut. A Reserve Bank of India committee has recommended setting up a special category of lenders who would cater to small businesses and households, to expand the number of customers with access to banking services. These banks would focus onproviding payment services and deposit products.  Indian banks want the free use of automated teller machines to be capped at five transactions in a month including that of the bank in which the account is active. This follows state government order to banks to install security guards at ATM booths after a woman banker was assaulted in Bangalore. The government is likely to present a vote on Account in mid-February. The annual Economic Survey will be tabled later in Parliament along with the full Budget. A full Budget for 2014/15 is likely to be present in July by the new government formed after the General Election. The government will soon launch an internet spy system, called Netra, to detect malafide messages. Security agency will deploy the system to capture dubious voice traffic on applications such as Skype and Google Talk, as well as tweeters.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Abhijeet Mane

Designation :

Accounts Manager

Contact No.:

91-9145239125

Date :

08.02.2014

 

 

LOCATIONS

 

Registered Office / Factory :

C-7-8(2), MIDC, Bhosari, Pune-411026, Maharashtra, India

Tel. No.:

Not Available

Mobile No.:

91-9145239125 [Mr. Abhijeet Mane]

Fax No.:

Not Available

E-Mail :

accounts@genpharma.net

Area :

30000 Sq. Ft.

Location :

Owned

 

 

Corporate Office :

B-207-216, 2nd Floor, Shankar Parvati Chambers, Above Kotak Mahindra Bank ATM, Dhole Patil Road, Pune-411001, Maharashtra, India

Tel. No.:

91-20-41501300

 

 

DIRECTORS

 

AS ON 30.09.2010

 

Name :

Ioan Biris

Designation :

Director

Address :

3161, Rue, De Cadillac, Montreal Quebec, Canada, Hin2V9

Date of Appointment :

23.11.2003

Din No.:

01874380

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230PN2003PTC130003

GENPHARMA (INTERNATIONAL) PRIVATE LIMITED

Director

23/11/2003

23/11/2003

-

Active

NO

2

U72200KA2005PTC037362

CEM SOLUTIONS PRIVATE LIMITED

Managing director

30/09/2005

30/09/2005

-

Active

NO

3

U24232MH2007PTC176313

MEDICINE 4 YOU PHARMA PRIVATE LIMITED

Director

29/11/2007

29/11/2007

-

Active

YES

4

U24110KA2011PTC058879

HERMES PHARMA LOGISTICS PRIVATE LIMITED

Director

31/05/2011

31/05/2011

15/06/2011

Strike off

NO

 

 

Name :

Sabita Budhiman Limbu

Designation :

Director

Address :

3161, Rue, De Cadillac, Montreal Quebec, Canada, Hin2V9

Date of Birth/Age :

03.10.1984

Date of Appointment :

29.01.2008

Din No.:

01868038

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U64202KA2006PTC039104

ALLO TEL WORLD PRIVATE LIMITED

Director

12/10/2007

12/10/2007

Strike off

NO

2

U24232MH2007PTC176313

MEDICINE 4 YOU PHARMA PRIVATE LIMITED

Director

29/11/2007

29/11/2007

Active

YES

3

U24230PN2003PTC130003

GENPHARMA (INTERNATIONAL) PRIVATE LIMITED

Director

29/01/2008

29/01/2008

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Abhijeet Mane

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2010

 

Names of Shareholders

 

No. of Shares

Ioan Biris

 

784330

Abani Kanta Patra

 

11250

 

 

 

TOTAL

 

795580

 

AS ON 30.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

99.00

Others

 

1.00

TOTAL

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Medicines.

 

 

Exports :

 

Products :

Pharmaceutical Formulation

Countries :

·         Sri Lanka

·         Uzbekistan

·         Latin America

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Suppliers :

Diamond Corporation, Mumbai

 

 

Customers :

Wholesalers and Retailers

 

·         Suvarna Fabrotech Private Limited

 

 

No. of Employees :

130 [Approximately] 

 

 

Bankers :

HDFC Bank, Vashi Branch, Mumbai, Maharashtra, India

 

 

Facilities :

--

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

SPP Associates

Chartered Accountants

Address :

21, Ground Floor, Akhurath CHS, Plot No. 11, Sector 14, Sanpada, Navi Mumbai-400705, Maharashtra, India

PAN No:

AAPFS6782D

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

2100000

Equity Shares

Rs.10/- each

Rs.21.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

795580

Equity Shares

Rs.10/- each

Rs.7.956 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

7.956

6.744

1.125

2] Share Application Money

0.000

0.000

24.513

3] Reserves & Surplus

156.194

131.950

19.577

4] (Accumulated Losses)

(42.201)

(32.427)

(23.134)

NETWORTH

121.949

106.267

22.081

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.599

0.629

5.129

TOTAL BORROWING

0.599

0.629

5.129

DEFERRED TAX LIABILITIES

0.807

0.000

0.000

 

 

 

 

TOTAL

123.355

106.896

27.210

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

103.055

16.181

17.721

Capital work-in-progress

3.842

51.230

0.449

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

18.002

4.259

3.592

 

Sundry Debtors

11.758

7.239

3.152

 

Cash & Bank Balances

0.419

7.260

0.947

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

12.585

26.363

3.489

Total Current Assets

42.764

45.121

11.180

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

23.404

5.431

1.331

 

Other Current Liabilities

3.483

0.931

0.971

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

26.887

6.362

2.302

Net Current Assets

15.877

38.759

8.878

 

 

 

 

MISCELLANEOUS EXPENSES

0.581

0.726

0.162

 

 

 

 

TOTAL

123.355

106.896

27.210

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

54.960

17.792

6.922

 

 

Other Income

0.130

0.267

0.000

 

 

TOTAL                                     (A)

55.090

18.059

6.922

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Raw Materials Consumed

24.681

3.795

4.149

 

 

Purchase of Finished Goods

11.524

6.933

1.613

 

 

Manufacturing Expenses

18.416

10.518

10.460

 

 

Administrative and Selling Expenses

8.475

5.070

5.245

 

 

Miscellaneous Expenses Written Off 

0.000

0.163

0.162

 

 

Prior Period Items

0.000

0.061

0.000

 

 

Decrease/Increase in Finished Stocks

(6.550)

(1.012)

0.800

 

 

TOTAL                                     (B)

56.546

25.528

22.429

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

(1.456)

(7.469)

(15.507)

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.013

0.006

0.004

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

(1.469)

(7.475)

(15.511)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

7.497

1.698

1.774

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                (G)

(8.966)

(9.173)

(17.285)

 

 

 

 

 

Less

TAX                                                                  (H)

0.807

0.120

0.084

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

(9.773)

(9.293)

(17.369)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(32.427)

(23.134)

(5.765)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(42.200)

(32.427)

(23.134)

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(13.69)

(13.78)

(205.64)

 

 

Particulars

 

 

31.03.2013

31.03.2012

Sales Turnover [Approximately]

 

12.000

43.000

 

 

Due to competition in the market order are less

 

Expected Sales (2013-14) : Rs.120.000 Millions.

 

The above information has been parted by Mr. Abhijeet Mane.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

(17.74)

(51.45)

(250.92)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(16.31)

(51.55)

(249.71)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(6.15)

(14.96)

(59.80)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.07)

(0.09)

(0.78)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.01

0.23

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.59

7.09

4.85

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last five years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

Yes

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

PAN of Proprietor/Partner/Director, if available

No

32]

Date of Birth of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR COMPANY.

 

 

 

CASE DETAILS

 

CASE TYPE

SUM CASE

FILING NO.

424633/2012     FILING DATE: 02-08-2012

REGISTRATION NO.

424633/2012     REGISTRATION DATE: 02-08-2012

CASE CODE

203404246332012

 

 

CASE STATUS

FIRST HEARING DATE

26-11-2012

NEXT HEARING DATE

18-03-2014

PURPOSE OF HEARING

UNREADY BOARD

COURT NO AND JUDGE

18 - JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

 

 

 

PETITIONER(S) AND ADVOCATE(S)

PETITIONER - THE STATE--ROC--
ADDRESS - PMT BLDG. DECCAN, PUNE.4.
ADVOCATE - 

 

 

 

 

RESPONDENT(S) AND ADVOCATE(S)

RESPONDENT – GENPHARMA INTERNATIONAL PRIVATE LIMITED ETC. 2

ADDRESS - MIDC BHOSARI, PUNE.
ADVOCATE - 

 

 

 

 

ACTS

UNDER ACT(S)

---

UNDER SECTION(S)

---

SUBJECT

 

 

 

 

LOWER COURT INFORMATION

COURT NO AND NAME

---

CASE NO AND YEAR

---

CASE DECISION DATE

---

 

 

 

FIR DETAILS

POLICE STATION

--

FIR NO.

--

YEAR

0

 

 

 

HISTORY OF CASE HEARING

REGN. NO.

JUDGE

BUSINESS ON DATE

HEARING DATE

PURPOSE OF HEARING

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

26-11-2012

07-02-2013

UNREADY BOARD

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

07-02-2013

09-04-2013

UNREADY BOARD

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

09-04-2013

04-07-2013

UNREADY BOARD

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

04-07-2013

24-09-2013

UNREADY BOARD

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

24-09-2013

23-11-2013

UNREADY BOARD

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

23-11-2013

17-01-2014

UNREADY BOARD

424633/2012

JUDICIAL MAGISTRATE F.C. ANTI-CORRUPTION, PUNE

17-01-2014

18-03-2014

UNREADY BOARD

 

 

WRIT INFORMATION

REGN. NO.

APPELLATE CASE NO.

APPELLATE AUTHORITY

DATE OF RECIEPT

 

CASE TRANSFER DETAILS BETWEEN THE COURTS

REGN. NO.

TRANSFER DATE

FROM COURT NO 
AND JUDGE

TO COURT NO 
AND JUDGE

 

 

 

 

Unsecured Loan

As on 31.03.2010

[Rs. in Millions]

As on 31.03.2009

[Rs. in Millions]

Director’s Loan Biris

0.000

0.030

CEM Solutions Private Limited, India

0.599

0.599

TOTAL

0.599

0.629

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.32

UK Pound

1

Rs.101.78

Euro

1

Rs.84.68

 

 

INFORMATION DETAILS

 

Information Gathered by :

HNA

 

 

Report Prepared by :

TPT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.